From DNA to Genomes in 50 Years  by Sweet, Deborah
Cell, Vol. 113, 563–564, May 30, 2003, Copyright 2003 by Cell Press
CommentaryFrom DNA to Genomes in 50 Years
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phase information for solving protein crystal structures.
For DNA biology, after the double helix itself came the
genetic code, the “central dogma,” semi-conservativeMeetings held in late April to mark the 50th anniversary
replication, sequencing, and of course the vast array ofof the elucidation of the DNA double helix covered the
subjects and technologies that come under the umbrellapast, present, and future of DNA biology.
of molecular biology. Mere words seem rather inade-
quate to express the impact that these advances haveEven in their wildest dreams, it seems unlikely that back
had on science as we now know it. The Royal Societyin 1953 Watson and Crick could have imagined how far
meeting in London showcased the current status of DNADNA science would develop in 50 years. We’ve come
research. David Sherratt and Steve West organized aall the way from their initial description of the structure
two-day program that covered DNA replication, recom-of DNA to the announcement of a refined and almost
bination, and repair, and related topics such as chromo-complete human genome sequence, with many land-
some structure and genetic instability during tumorigen-marks in between. For most of us, molecular biology
esis. Taken together, these presentations provided aand genomics are so integrated into our scientific psy-
dramatic illustration of how far the DNA biology fieldche that we rarely stop to think how remarkable these
has progressed. At this point, not only do we have aachievements are. The “DNA 50” anniversary gave us
substantial amount of information about how DNA isan opportunity to do so, and also to think about how
manipulated and maintained, we also are beginning tobiology will move forward in the post-genomic era.
understand how the protein-nucleic acid complexes in-Last month saw the culmination of the festivities held
volved function at a detailed structural level. A strikingto mark this historic occasion. The celebrations kicked
example of this progress was the animation Tom Steitzoff in earnest at the end of February, the time that the
showed in London of T7 RNA polymerase in action (withactual discovery was made, with the Cold Spring Harbor
a musical accompaniment), based on information from asymposium on “The Biology of DNA.” Then, to coincide
variety of different crystal structures. Also, in Cambridgewith the anniversary of publication of the structure paper
Tim Richmond unveiled a new high-resolution structureon April 25, the MRC Laboratory of Molecular Biology
of the nucleosome showing how DNA is deformed as it(LMB), together with the Cavendish Laboratory and the
bends around the nucleosome core.Sanger Institute, organized two one-day meetings in
The past and present got well-deserved recognition,Cambridge, United Kingdom. The first, on April 25, fo-
but what about the future? What happens next? As onecused on the 50 years of the double helix, while the
might expect, much of the forward-looking analysis in-second, on the next day, was dedicated to the LMB
cluded in the “DNA 50” celebrations focused on the
itself and its scientific legacy. Just before these, the
future of genomics, where there is a lot to be excited
Royal Society in London held a discussion meeting on
about. The technology surrounding the acquisition and
“Replicating and reshaping DNA.” Those fortunate analysis of genomic and gene expression data is improv-
enough to be able to attend these events were treated ing continuously. A realistic goal for the near future is
to a mixture of historical accounts, reminiscences, and to use cross-species genome sequence comparisons
modern science. The great and the good gathered for to help with delineating coding genes and, perhaps more
the science and the socializing, including gala dinners importantly, in understanding the functions and regula-
in New York, London, and Cambridge. tory significance of non-coding regions. Existing se-
Not surprisingly, much of the historical discussion at quences are already providing insights along these lines,
the meetings, and in the myriad of journal and newspa- and in Cambridge John Sulston and Gerry Rubin gave
per articles that have also appeared, focused on what updates about the history and current status of genome
happened in 1953. We learned about the circumstances projects from different organisms, including Drosophila,
that brought Watson and Crick together, the synergy C. elegans, and humans. We look forward to the day
they developed, and the contributions they both made. when completed genomes for other species, including
We also heard about other scientists working on the chimpanzee, zebrafish, and chicken, are available and
problem at the same time, including Rosalind Franklin added to the repertoire.
and Maurice Wilkins, whose investigations made Wat- Genomic comparison within a species also has great
son and Crick’s insights possible. Aaron Klug’s presen- potential. Several speakers in London and Cambridge
tation in Cambridge included excerpts from Rosalind discussed the ways in which analysis of SNP and se-
Franklin’s notebooks, providing a fascinating insight into quence data from humans should give us insights into
scientific thinking at the time. Several of the other speak- the basis for variation between individuals. Perhaps one
ers devoted time to giving a historical perspective, and day we will understand the genetics behind even com-
referred back to original insights from many decades plex characteristics like the human face or the relative
ago that preceded (and occasionally even predicted) contributions of genome and environment to human be-
modern biology. We were also reminded that 1953 was havior. In his summing up in London, Sydney Brenner
a pioneering year for biological science in other ways: outlined a vision for population-level genomics in which
30,000 or even 100,000 different genomes are se-it saw the first description of the interdigitating structure
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quenced in parallel, to form a resource for this type of
research. This may seem a daunting task, but if we
consider the progress of the past 50 years, perhaps it
isn’t such an unrealistic goal.
Aside from the basic biological interest in understand-
ing human variation, there are also more practical bene-
fits. Genomic information, combined with gene expres-
sion analysis, could be used to target therapies to
patients most likely to benefit from them and to avoid
treating those likely to suffer from adverse side effects.
In his presentation in Cambridge, George Poste covered
several issues related to health care applications. He
discussed how such strategies are already being devel-
oped in the treatment of some diseases, such as HIV,
and how they have the potential to become much more
widespread. Harold Varmus also outlined the ways in
which genomic and expression profiling strategies are
at the vanguard of current cancer biology. However,
concomitant with this developing technology comes a
moral responsibility to ensure that the information is
used appropriately: the ethics of data collection and
application are important to consider, as are efforts to
ensure that these advanced technologies are used to
benefit the health of everyone, not just a few.
This strong emphasis on “big science” led inevitably
to questions about whether the advent of the genomic
era marks the end of “small science” as we now know
it. Opinions vary, but the answer really has to be no. As
Sydney Brenner pointed out, information is not much
use without analysis—new insights do not emerge magi-
cally from large data sets without interpretation. Instead,
we should think of genomic information as a resource,
and one that allows scientists to ask questions in ways
that weren’t possible before. Of course, broad use of
this information does depend on it being accessible and
user-friendly for researchers from a wide range of fields,
and this is one of the main aims of publicly funded
sequencing and other large-scale projects. George
Poste, in particular, highlighted the strong arguments
for standardization of data presentation and storage,
such as the MIAME initiative for array data, to ensure
that as many researchers and medical professionals as
possible can use the information being accumulated in
a meaningful way. Perhaps this, as much as anything,
represents a challenge for scientists in the post-geno-
mic era: making sure that the tools available are ex-
ploited to their maximum potential.
